## Abstract The preparation of deuterium labelled catecholamines and their metabolites is described. The procedures involve simple treatment of the compounds in DC1/D~2~O solution. Mass spectra of these labelled compounds — as their PFP or TFA derivative — are presented. The relative intensity of i
Preparations of deuterium labelled guvacine and isoguvacine
✍ Scribed by Søren Brøgger Christensen; Povl Krogsgaard-Larsen
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- French
- Weight
- 443 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The preparations of guvacine hydrochloride, in which a proton in position 2 (11) and protons in positions 2 and 5 (10) are selectively exchanged by deuterium, and of [2,6‐^2^H]isoguvacine hydrobromide (14a) are described. The deuterium labelled guvacine salts 10 and 11 were synthesized by triethylamine catalyzed exchange of hydrogen for deuterium in methyl N‐nitroso‐1,2,5,6‐tetrahydropyridine‐3‐carboxylate (3) followed by denitrosation and hydrolysis. Treatment of N‐nitroso‐1,4,5,6‐tetrahydropyridine‐3‐carboxylic acid with methanolic thionyl chloride gave 3,4,5,6‐tetrahydropyridin‐3‐on ketoxime. Compound 14a was prepared by sodium borodeuteride reduction of 4‐ethoxycarbonyl‐1‐methylpyridinium iodide (12) followed by N‐demethylation and hydrolysis of the intermediate.
📜 SIMILAR VOLUMES
## Abstract The synthesis of d, l, ‐12‐bromocamptothecin (**2d**) from camptothecin (**1**) is described. Reduction of the bromo derivative **2d** with tritium gas in the presence of palladium on carbon afforded d, l‐camptothecin 12‐^3^H having a specific activity of 29 Ci/mmol. A simpler labelling
## Abstract The chemoenzymatic preparation of optically‐active [3,3,3‐^2^H~3~]‐ibuprofen and [2‐^2^H]‐ibuprofen are described.
## Abstract A mild exchange labeling procedure utilizing O‐deuterated or O‐tritiated t‐butanol with sodium catalysis afforded isotope exchange in the α‐hydrogen position of the amide N‐t‐butyl‐2‐(5‐benzyloxy‐6‐hydroxymethyl‐2‐pyridyl)‐2‐hydroxy‐acetamide, thereby extending the utility of this appro
## Abstract Deprotonation of paraherquamide (1a) at C‐24 and subsequent deuteration (or tritiation) is described. The procedure afforded 24‐^2^H‐paraherquamide (1b) with 66% deuterium incorporation at C‐24. Modification of the deuteration procedure to allow the introduction of tritium resulted in t